Search for: "MERCK " Results 1041 - 1060 of 3,283
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Nov 2005, 4:54 pm
[JURIST] The first federal Vioxx trial, in which Evelyn Irvin Plunkett is suing pharmaceutical giant Merck [corporate website] for the death of husband Richard "Dicky" Irvin of a heart attack in May 2001, began Tuesday with an opening statement from Plunkett's lawyer, who told jurors that Irvin died as a direct result of taking the painkiller Vioxx [JURIST news archive] for about a month and that [read post]
6 Mar 2006, 11:23 am
Merck, the former producer of Vioxx, has received two defense verdicts involving the pain killer to date but lost a third trial that resulted in a $253 million dollar jury verdict for the widow of a Wal-Mart employee who died from a heart attack while taking Vioxx [read post]
6 Apr 2007, 11:34 am
Vioxx's maker, Merck & Co., is asking the Food and Drug Administration to approve a successor to the pulled drug Vioxx that was found to increase the risk of heart attack and stroke. [read post]
10 Jan 2010, 6:40 pm by Varun R. Chhonkar
This year at least 20 odd drug molecules will be going off-patent in the United States including (1) Merck’s anti-hypertension molecule Losartan, active ingredient of Cozaar and Hyzaar franchise, (2) Eisai’s anti-dementia molecule Donepezil, active ingredient of Aricept and Aricept ODT (3) Sanofi-Aventis’s anti-cancer molecule Docetaxel, active ingredient of Taxotere franchise, (4) Pfizer’s [read post]
5 Jun 2006, 8:28 am
In this trial, the drug manufacture Merck & Co. is defending its pain mediation against the allegations of Elaine Doherty, a 68-year-old grandmother who suffered a heart attack after taking Vioxx for 3 years. [read post]
31 Mar 2016, 1:18 pm by Lawrence B. Ebert
We accordinglyfollow the Second Circuit’s decision in GeorgeBasch as reaffirmed in Merck. [read post]
1 May 2013, 6:00 am
Over 1,000 plaintiffs are suing Merck & Co. in the Eastern District of Missouri over the birth control NuvaRing. [read post]
20 Mar 2009, 2:20 am
The column returns to honor two lawyers behind two of the biggest, and most significant, transactions so far this year--Cooley Godward's Richard Climan advised Gilead Sciences on its $1.4 billion acquisition of CV Therapeutics, while Fried Frank's David Shine represented Merck in its $41 billion merger with Schering-Plough. [read post]
4 Dec 2009, 2:22 am
The Supreme Court considers the ‘inquiry notice’ standard in federal securities fraud cases Simpson Thacher & Bartlett LLP "The Supreme Court heard oral arguments yesterday in Merck & Co, Inc. v. [read post]
17 Sep 2005, 4:09 am
[JURIST] The New Orleans-based federal judge charged with co-ordinating [JURIST report] the approximately 1800 pending federal lawsuits relating to the withdrawal of the painkiller Vioxx [JURIST news archive] from pharmacists' shelves last year has ruled that the first federal trial against Vioxx-manufacturer Merck will take place in Houston beginning November 28. [read post]
27 Dec 2013, 4:55 am by Gene Quinn
Merck and GlaxoSmithKline Collaborate on Regimen for Advanced Renal Cell Carcinoma. [read post]
15 Apr 2007, 1:43 pm
Merck & Co. had pulled a similar arthritis drug, Vioxx. [read post]
3 May 2005, 4:01 pm
A state court judge has ordered Vioxx manufacturer Merck & Co. to begin settlement talks with the widow of an Alabama man who blames the pain medication for her husband's death.This does not mean it will settle. [read post]
5 Aug 2015, 4:30 am by Barry Sookman
Computer and Internet Updates for 2015-08-03: Commissioning party owns copyright in logo Atelier Eighty Two Lt… http://t.co/IPWmsVQC3A -> Computer and Internet Updates for 2015-08-03 http://t.co/eVxOrd9oGJ -> Canada's FCA Upholds C$180 Million Judgment in Favour of Merck Against Apotex in a Landmark Patent Damages Ruling http://t.co/WHbfEOd5GV -> [read post]
2 May 2008, 6:03 am
Merck report this week that more than ninety percent of eligible U.S. claimants have elected to participate in its $4.85 billion proposed Vioxx settlement, and the drugmaker extended the deadline to opt in.Merck said that, while it was satisfied with signing up the vast majority of potential participants, it was extending by two months -- until June 30 -- the deadline for remaining eligible former users of its withdrawn arthritis drug to enroll in its proposed settlement.Link here. [read post]
9 May 2007, 10:07 am
The Brazilian government's decision to override the patent rights of Merck's HIV/AIDS drug Stocrin (efavirenz) and buy reverse engineered generic versions of the drug at low cost has come as a boon for Indian pharmaceutical companies manufacturing generic versions of efavirenz such as Cipla, Ranbaxy, Aurobindo Pharma and Strides Arcolab. [read post]
20 May 2016, 6:15 am by Joseph Robinson
Merck’s communications were a complete offer because they were solicited and contained... [read post]